SAM
RNAM

Simplify Asset Management’s Avidity Biosciences RNAM Stock Holding History

Simplify Asset Management’s Portfolio RNAM Stock Details RNAM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-125,000
Closed -$3.69M – 100
2025
Q1 		$3.69M Hold
125,000
– – 0.14% 28
2024
Q4 		$3.63M Hold
125,000
– – 0.18% 35
2024
Q3 		$5.74M Hold
125,000
– – 0.27% 31
2024
Q2 		$5.11M Hold
125,000
– – 0.34% 30
2024
Q1 		$3.19M Hold
125,000
– – 0.19% 41
2023
Q4 		$1.13M Hold
125,000
– – 0.1% 69
2023
Q3 		$798K Hold
125,000
– – 0.09% 80
2023
Q2 		$1.39M Hold
125,000
– – 0.18% 68
2023
Q1 		$1.92M Buy
+125,000
New +$2.75M 0.28% 40

Other funds holding RNAM

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Simplify Asset Management's RNAM Position: Q2 2025 in Review

Simplify Asset Management sold out of Avidity Biosciences (RNAM) in Q2 2025, closing a stake of 125,000 shares — an estimated $3.69M sold.

Simplify Asset Management first reported a position in RNAM in Q1 2023 and held it in 9 quarters. The position peaked at $5.74M in Q3 2024. 206 funds tracked by Wall St. Rank hold RNAM as of Q2 2025.

  • Simplify Asset Management reported no remaining Avidity Biosciences position as of Q2 2025 after selling out during the quarter.
  • Simplify Asset Management sold 125,000 Avidity Biosciences shares in Q2 2025, an estimated $3.69M.
  • Simplify Asset Management first reported a position in Avidity Biosciences in Q1 2023 and held it in 9 quarters.
  • Simplify Asset Management's Avidity Biosciences position peaked at $5.74M in Q3 2024.
  • 206 funds tracked by Wall St. Rank held Avidity Biosciences as of Q2 2025.

Based on Simplify Asset Management's 13F filing for Q2 2025, filed 7 Aug 2025.